Grintek Biopolymer India Profile
Key Indicators
- Authorised Capital ₹ 9.90 M
as on 09-12-2024
- Paid Up Capital ₹ 9.90 M
as on 09-12-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.99 Cr
as on 09-12-2024
- Revenue %
(FY 2023)
- Profit -799.09%
(FY 2023)
- Ebitda -2637.39%
(FY 2023)
- Net Worth -2888.94%
(FY 2023)
- Total Assets 150.05%
(FY 2023)
About Grintek Biopolymer India
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.90 M and a paid-up capital of Rs 9.90 M.
The company currently has active open charges totaling ₹3.99 Cr.
Suresh Nayak, Kodisvarane, Balu, and One other member serve as directors at the Company.
- CIN/LLPIN
U25209PY2021PTC008733
- Company No.
008733
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2021
- Date of AGM
24 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Company Details
- Location
Pondicherry, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Grintek Biopolymer India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Nayak  | Managing Director | 24-Aug-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kodisvarane | Director | 01-Jul-2024 | Current |
| Balu | Director | 01-Jul-2024 | Current |
| Jeyasubramanian | Director | 01-Jul-2024 | Current |
Financial Performance of Grintek Biopolymer India.
Grintek Biopolymer India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 799.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2888.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grintek Biopolymer India?
Unlock access to Grintek Biopolymer India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 19 Aug 2022 | ₹3.99 Cr | Open |
How Many Employees Work at Grintek Biopolymer India?
Grintek Biopolymer India has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grintek Biopolymer India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grintek Biopolymer India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
